Company: BLCO
Filing Date: 2025-07-30
Form Type: 10-Q
Source: 0001860742-25-000018
Chunk: 15

Company: Bausch & Lomb Corp
Filing Date: 2025-07-30
Form: 10-Q
Item: Item 8
Chunk 15
---
 net in the Condensed Consolidated Balance Sheets. For the six months ended June 30, 2025, included in Payments and credits in 

8

the table above, are payments made, or to be made, by Novartis, on behalf of the Company for Rebates, in accordance with the agreements associated with the 2023 acquisition of XIIDRA® (lifitegrast ophthalmic solution) and certain other ophthalmology assets (the “XIIDRA Acquisition”).Six Months Ended June 30, 2024(in millions)DiscountsandAllowancesReturnsRebatesChargebacksDistributionFeesTotalReserve balance, January 1, 2024$141 $66 $226 $67 $18 $518 Current period provision208 48 688 318 37 1,299 Payments and credits(215)(36)(481)(323)(25)(1,080)Reserve balance, June 30, 2024$134 $78 $433 $62 $30 $737 Included in Rebates in the table above are cooperative advertising credits due to customers of approximately $39 million and $35 million as of June 30, 2024 and January 1, 2024, respectively, which are reflected as a reduction of Trade receivables, net in the Condensed Consolidated Balance Sheets.  For the six months ended June 30, 2024, included in Payments and credits in the table above, are payments made, or to be made, by Novartis, on behalf of the Company, in accordance with the agreements associated with the XIIDRA Acquisition in September 2023.Contract Assets and Contract LiabilitiesThere are no contract assets for any period presented. Contract liabilities consist of deferred revenue, the balance of which is not material to any period presented.Allowance for Credit LossesAn allowance is maintained for potential credit losses. The Company estimates the current expected credit loss on its receivables based on various factors, including historical credit loss experience, customer credit worthiness, value of collaterals (if any), and any relevant current and reasonably supportable future economic factors. Additionally, the Company generally estimates the expected credit loss on a pooled basis when customers are deemed to have similar risk characteristics. Trade receivable balances are written off against the allowance when it is deemed probable that the trade receivable will not be collected. Trade receivables, net are stated net of certain